Skip to content
OpenCapital
Get started

Fulcrum Therapeutics, Inc. FULC Q2 2025 earnings

Reported July 29, 2025 · Before market open

EPS-$0.28Beat by $0.01
EPS estimate-$0.29

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.21

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.06Q4 2025-$0.31In lineQ3 2025-$0.31Miss by $0.02
Q2 2025-$0.28Beat by $0.01
Q1 2025-$0.28Beat by $0.01Q4 2024-$0.31Miss by $0.03

Ask the moment Fulcrum Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fulcrum Therapeutics, Inc. report Q2 2025 earnings?
Fulcrum Therapeutics, Inc. (FULC) reported Q2 2025 earnings on July 29, 2025 before market open.
What were Fulcrum Therapeutics, Inc.'s Q2 2025 revenue and EPS?
Fulcrum Therapeutics, Inc. reported eps of $-0.28 for Q2 2025.
Did Fulcrum Therapeutics, Inc. beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.29 by $0.01.
Where can I find Fulcrum Therapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-099407) directly on SEC EDGAR. The filing index links above go to sec.gov.